Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better.

From the week of the 5th of May, we are planning to work on 19 projects, including:

Reimbursement

1. Delivering reimbursement analysis for minimally invasive cardiac procedures in Italy and Poland
2. Delivering an analysis of the funding landscape for transfusion technology in Germany
3. Delivering market access strategy for several technologies in ophthalmological, urological, and oncological fields in Belgium and the Netherlands
4. Working on analysis of tender requirements for surgical equipment in England, France, Italy, Poland, and Spain
5. Working on desk research of the funding opportunities for decision support tools in clinical epidemiology at the EU level and in individual European countries (England, France, Germany, Italy, and Spain)
6. Working on an update of coding guides for physicians for technology in the cardiology field in England, Germany, and Switzerland
7. Working on reimbursement analysis for medical devices in cardiovascular and orthopedic areas in several European countries
8. Working on reimbursement analysis for gastrointestinal diagnostic technology in Denmark, Norway, and Sweden
9. Initiating work on reimbursement analysis for diagnostic tests in the neurology area in Switzerland
10. Initiating work on reimbursement analysis for diagnostic tests in obstetric care in England, France, Germany, Italy, Spain, and Switzerland
11. Initiating work on reimbursement analysis for delivery of a medication in outpatient settings in England, France, Germany, and Sweden

HEOR

1. Working on the development of a health economic model for in-vitro diagnostic test in England, France, Germany, Italy, and Spain
2. Working on the development of an early value dossier for wound treatment technology in European countries 
3. Finalizing the development of an HTA submission dossier in the UAE
4. Finalizing the systematic literature review for minimally invasive neurological technology in Parkinson's disease
5. Finalizing the development of an HTA national submission dossier in Sweden
6. Working on analysis of HTA requirements for surgical equipment in ten European countries
7. Working on a literature review for several technologies in the neurology field
8. Working on the development of a health economic model for minimally invasive neurological technology in France

Let us know if you need any market access or HEOR support for your medical technology in Europe.